Old Web
English
Sign In
Acemap
>
authorDetail
>
Z M Zhu
Z M Zhu
Zhengzhou University
Internal medicine
Lymphoma
Medicine
Cancer research
Biology
4
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
[Efficacy and safety of PD-1 inhibitor combined with chemotherapy in the primary treatment of phase III/IV extranodal nasal-type natural killer/T cell lymphoma].
2021
National Medical Journal of China
Y B Liu
Xiaoli Yuan
Rongjun Ma
L. Jiang
Lei Wang
Z M Zhu
Show All
Source
Cite
Save
Citations (0)
Research Progress of DCLK1 Inhibitors as Cancer Therapeutics.
2021
Current Medicinal Chemistry
Cheng Linna
Shenzhen Huang
Lijuan Chen
Xiaoyan Dong
Zhang Lei
C Y Wu
Kaihong Ye
Fengmin Shao
Z M Zhu
Rick F. Thorne
Show All
Source
Cite
Save
Citations (0)
G protein nucleolar 3 promotes Non-Hodgkin lymphoma progression by activating the Wnt/β-catenin signaling pathway.
2021
Experimental Cell Research
Rongqin Dai
Meirong Wu
Yin Zhang
Z M Zhu
Jie Shi
Show All
Source
Cite
Save
Citations (0)
Clinical and biological characteristics and prognosis of patients with biclonal multiple myeloma
2021
Chinese Journal of Hematology
W. Cheng
Y-L Li
Zongqiang Huang
Zhao-Bo Li
X Y Dong
B J Shang
Lina Zhang
Jie Shi
Z M Zhu
Show All
Source
Cite
Save
Citations (0)
1